BEST UNLIMITED TURBO LONG CERTIFICATE - MERCK & CO. | Real-time Borsa Italiana 13:49:53 03/06/2024 BST | ||
| 1.287 EUR | -0.54% |
|
| 1 month | -25.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 1.287 | -0.54% |
| 31/05/24 | 1.294 | +8.74% |
| 30/05/24 | 1.19 | -10.05% |
| 29/05/24 | 1.323 | -0.75% |
| 28/05/24 | 1.333 | -16.43% |
Real-time Borsa Italiana
Last update June 03, 2024 at 01:49 pm
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Société Générale
|
| S34506 | |
| ISIN | DE000SW7EWU0 |
| Date issued | 12/03/2024 |
| Strike | 112.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.165 € |
|---|---|
| Lowest since issue | 0.925 € |
| Spread | 0.09 € |
| Spread % | 6.77% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- S34506 Certificat
